RonaldWDayMD
Pediatric Cardiology • Salt Lake City, UTProfessor, Pediatrics, University of Utah School of Medicine
Dr. Day is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2952 East Pineview Drive
Salt Lake City, UT 84121Phone+1 801-580-0710
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Cardiology, 1987 - 1990- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1985 - 1987
University of Utah School of MedicineClass of 1984
Certifications & Licensure
UT State Medical License 1991 - 2026- American Board of Pediatrics Pediatric Cardiology
Clinical Trials
- A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2017 Oct 24
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension Start of enrollment: 2020 Jan 16
- A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension Start of enrollment: 2012 Jul 17
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsLong-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.Mark-Jan Ploegstra, David Dunbar Ivy, Maurice Beghetti, Damien Bonnet, Dursun Alehan
European Heart Journal. Quality of Care & Clinical Outcomes. 2024-01-12 - Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure.Dana R Tower, Ronald W Day, Tighe Marrone, Rachel Palmquist, Lincoln D Nadauld
Cold Spring Harbor Molecular Case Studies. 2023-12-01 - Evaluation of methemoglobin as an intravascular contrast agent: T1 relaxation time effect in a rabbit model.Seong-Eun Kim, J Scott McNally, Matthew D Alexander, Matthew S Zabriskie, Dennis L Parker
Magnetic Resonance Imaging. 2023-11-01
Journal Articles
- Factors influencing pulmonary arterial pressure and outcome in three related patients with Cantú syndromeDay RW, Call BJ, Rare Disease and Orhan Drugs Journal, 9/27/2023
Press Mentions
Nu-Med plus, Inc. Announces Prominent Research Lab to Utilize Its New Advanced Nitric Oxide Delivery Product for StudySeptember 11th, 2018
Grant Support
- Using Intracellular Methemoglobin as a Contrast Agent for Magnetic Resonance AngiographyNational Institutes of Health. National Center for Advancing Translational Sciences2019–2020
Committees
- Member, Rare Disease Advisory Council of Utah 2023 - Present
Professional Memberships
- Member
- Pulmonary Hypertension AssociationMember
- Society for Pediatric ResearchMember
- Pediatric Pulmonary Hypertension NetworkMember
- Pulmonary Vein Stenosis NetworkMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
